| Date | Title | Description |
| 12.09.2024 | CorFlow Therapeutics Secures €44 Million to Revolutionize Heart Attack Treatment | CorFlow Therapeutics is on a mission. The Swiss company has just raised €44 million in a Series B funding round, co-led by Broadview Ventures and Panakes Partners. This influx of capital is not just a financial boost; it’s a lifeline for pa... |
| 12.09.2024 | CorFlow Therapeutics raises €44 million in Series B round |
Co-led by Broadview Ventures and Panakes Partners, CoFlow’s series B round received strong continued support from 415 Capital, its initial VC investor and largest shareholder. Merieux Equity Partners, Laerdal Million Lives Fund, Wellington... |
| 10.02.2022 | New US Laboratory and funding for HAYA Therapeutics | |
| 23.06.2021 | RapidPulse Launches with $15M for Ischemic Stroke Therapy | – RapidPulse, Inc., a Miami-based medical device company developing a novel aspiration system to treat ischemic stroke, today announced it has raised $15M in Series A funding led by Santé Ventures who was joined by Epidarex Capital, Hattera... |
| 20.05.2021 | HAYA Therapeutics closes CHF 18 million seed round | |
| 20.05.2021 | HAYA Therapeutics closes CHF 18 million seed round | Along side Broadview Ventures, HAYA Therapeutics’ seed round attracted additional investors including Apollo Health Ventures, BERNINA BioInvest, 4See Ventures, Schroder Adveq and Viva BioInnovator. The startup will use the funds from the fi... |
| 22.03.2016 | Daily funding roundup - March 22, 2016 | Syntimmune bagged $26M; FineHeart recieved investment from Broadview Ventures; Shiftboard landed $4M
St. Louis, Missouri-based ClubReady, a software provider for the fitness and wellness industry, closed a Series A investment from Level Equ... |
| 10.03.2015 | Pulmokine Receives $1M Investment from Broadview Ventures | Pulmokine, a Rensselaer, NY-based biopharmaceutical company, received a $1m investment from Broadview Ventures.
The company intends to use the funds to advance its lead candidate, PK10571, into Phase 1 clinical trials in patients with pulmo... |
| 23.01.2015 | Medical device panel outlines pathways to market | By Erin Horan
Physicians often dream of creating new devices to help their patients, but few are able to bring a device to market. At a panel discussion earlier this month at Boston Children’s Hospital, an entrepreneur, a venture capitalist... |
| 20.11.2014 | InfoBionic attracts new investors for remote patient monitoring device for chronic conditions | Some of the cool technology bits includes a way for doctors to remotely adjust settings to reduce office visits. A “multipass” analysis tool helps eliminate false positives. Although it transmits a continuous signal of the patient’s heart r... |
| 09.04.2014 | Digital health startup’s device for detecting arrhythmia raises $17M | The healthcare startup led by Nancy Briefs claims that its cloud-based MoMe System is designed to have a seamless transition between holter, event, and mobile cardiac telemetry monitoring modes, according to a company statement.
Digital med... |
| 10.02.2014 | Remedy Pharmaceuticals Receives Investment from Broadview Ventures | Remedy Pharmaceuticals, a New York City-based clinical stage pharmaceutical company, received an investment from Broadview Ventures.
The amount of the deal was not disclosed.
The company intends to use the funds to accelerate its GAMES-RP c... |
| 31.07.2013 | Drug to replicate effects of gastric bypass surgery gets AHA backing | One reason why gastric bypass helps prevent Type 2 diabetes is it expedites the delivery of certain nutrients to the lower gut and improves the secretion of glucoregulatory gut hormones. Here’s BioKier’s description of its treatment: The or... |
| 22.02.2013 | Antibody could reduce longterm effects of myocardial infarction, cut readmissions | Walter Newman is the chief scientific officer for Decimmune and serves on the company’s business and advisory team. In a phone interview with MedCity News, Newman said the company had recently raised $2.25 million to help advance its treatm... |
| 21.12.2010 | Stereotaxis, Casenet, Capricor close out the year with new funding | UPDATED Dec. 21, 5:55 p.m.
Stereotaxis Inc. (NSDQ:STXS), Casenet LLC and Capricor Inc. each raised new funding through various financial instruments.
St. Louis, Mo.-based Stererotaxis closed on a $40 million credit facility that the company... |
| 18.12.2010 | Capricor Raises Nearly $2M | Capricor, Inc., a Los Angeles, CA-based biotechnology company that aims to create cardiac stem cell treatments to regenerate the heart and improve its function, raised nearly $2m from Broadview Ventures and private individual investors.
The... |
| - | Antibody could reduce longterm effects of myocardial infarction, cut readmissions | A lean startup is developing therapeutics using a monoclonal antibody to preserve cardiac tissue and help the body heal from the scarring that can result from the restoration of blood flow for a myocardial infarction. Its treatment could he... |
| - | InfoBionic attracts new investors for remote patient monitoring device for chronic conditions | InfoBionic, a company that helps doctors identify arrhythmias through its remote monitoring device, Mome Kardia, has raised the second tranche of a $17 million Series B round to commercialize the device following the initial fundraise in Ap... |
| - | Drug to replicate effects of gastric bypass surgery gets AHA backing | About 200,000 people undergo gastric bypass surgery each year and contribute to an estimated $147 billion in obesity-related healthcare costs. Many are patients who opt for the surgery as a way to treat or prevent Type 2 diabetes. But a bio... |
| - | Digital health startup’s device for detecting arrhythmia raises $17M | The number of digital health companies seeking a piece of the remote monitoring market hasn’t diminished investor interest. The cardiac monitoring industry alone is estimated to be worth $3 billion.InfoBionics has completed the first tranch... |
